The role of excessive versus acute administration of erythropoietin in attenuating hepatic ischemia-reperfusion injury

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 12, 2010, Pages 1130-1137

  Pappo, Orit ^a   Ben Ari, Ziv ^a   Shevtsov, Evgeni ^a,b   Avlas, Orna ^b   Gassmann, Max ^c   Ravid, Amiram ^b   Cheporko, Yelena ^b   Hochhauser, Edith ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Apoptosis; Caspase 3; Erythropoietin; In vivo; Ischemia reperfusion; Liver; Transgenic mice

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER ENZYME; RECOMBINANT ERYTHROPOIETIN; STRESS ACTIVATED PROTEIN KINASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SHAM PROCEDURE; WILD TYPE;

ANIMALS; APOPTOSIS; CASPASE 3; DNA, COMPLEMENTARY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HEPATOCYTES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; PHOSPHORYLATION; RANDOM ALLOCATION; REPERFUSION INJURY;

EID: 78650254889     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-091     Document Type: Article

References (28)

1. Bendinelli, P., Piccoletti, R., Maroni, P., and Bernelli-Zazzera, A. 1996. The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett. 398(2-3): 193-197. doi:10.1016/S0014-5793(96)01228-8. PMID:8977105.
2. Bogoyevitch, M.A. 2004. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc. Res. 63(2): 208-216. doi:10.1016/j.cardiores.2004.03.017. PMID:15249178.
3. Bradham, C.A., Stachlewitz, R.F., Gao, W., Qian, T., Jayadev, S., Jenkins, G., et al. 1997. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology, 25(5): 1128-1135. doi:10.1002/hep. 510250514. PMID:9141429.
4. Calvillo, L., Latini, R., Kajstura, J., Leri, A., Anversa, P., Ghezzi, P., et al. 2003. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. U.S.A. 100(8): 4802-4806. doi:10.1073/pnas.0630444100. PMID:12663857.
5. Chong, Z.Z., Kang, J.Q., and Maiese, K. 2002. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22(5): 503-514. doi:10.1097/00004647-200205000-00001. PMID:11973422.
6. Clavien, P.A., Harvey, P.R., and Strasberg, S.M. 1992. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation, 53(5): 957-978. doi:10.1097/00007890-199205000-00001. PMID:1585489.
7. Crenesse, D., Gugenheim, J., Hornoy, J., Tornieri, K., Laurens, M., Cambien, B., et al. 2000. Protein kinase activation by warm and cold hypoxia-reoxygenation in primary-cultured rat hepatocytes-JNK1/SAPK1 involvement in apoptosis. Hepatology, 32(5): 1029-1036. doi:10.1053/jhep.2000.19065. PMID: 11050053.
8. Fan, C., Yang, J., and Engelhardt, J.F. 2002. Temporal pattern of NFkB activation influences apoptotic cell fate in a stimuli-dependent fashion. J. Cell Sci. 115(Pt 24): 4843-4853. doi:10. 1242/jcs.00151. PMID:12432072.
9. Fan, C., Li, Q., Zhang, Y., Liu, X., Luo, M., Abbott, D., et al. 2004. IkBa and IkBb possess injury context-specific functions that uniquely influence hepatic NF-kB induction and inflammation. J. Clin. Invest. 113(5):. PMID:14991073.
10. Georgiev, P., Dahm, F., Graf, R., and Clavien, P.A. 2003. Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver. Curr. Pharm. Des. 12(23): 2911-2921. doi:10.2174/138161206777947588.
11. Greif, F., Ben-Ari, Z., Taya, R., Pappo, O., Kurtzwald, E., Cheporko, Y., et al. 2010. Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats. Liver Transpl. 16(5): 631-638. PMID:20440772.
12. Heinicke, K., Baum, O., Ogunshola, O.O., Vogel, J., Stallmach, T., Wolfer, D.P., et al. 2006. Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291(4): R947-R956. PMID:16690772.
13. Hochhauser, E., Pappo, O., Ribakovsky, E., Ravid, A., Kurtzwald, E., Cheporko, Y., et al. 2008. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. Apoptosis, 13(1): 77-86. doi:10. 1007/s10495-007-0155-8. PMID:18085440.
14. Jaeschke, H. 1996. Preservation injury: mechanisms, prevention and consequences. J. Hepatol. 25(5): 774-780. doi:10.1016/ S0168-8278(96)80253-4. PMID:8938560.
15. Jaeschke, H., and Lemasters, J.J. 2003. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology, 125(4): 1246-1257. doi:10.1016/S0016-5085(03)01209-5. PMID:14517806.
16. Liu, X., Xie, W., Liu, P., Duan, M., Jia, Z., Li, W., and Xu, J. 2006. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci. 78(19): 2255-2264. doi:10.1016/j.lfs.2005.09. 053. PMID:16336978.
17. Luedde, T., and Trautwein, C. 2006. Intracellular survival pathways in the liver. Liver Int. 26(10):. doi:10.1111/j.1478-3231.2006.01366.x. PMID:17105581.
18. Luedde, T., Assmus, U., Wustefeld, T., Meyer zu Vilsendorf, A., Roskams, T., Schmidt-Supprian, M., et al. 2005. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J. Clin. Invest. 2(1): 849-859.
19. Ravid, A., Koren, R., Rotem, C., Garach-Jehoshua, O., Glaser, T., and Liberman, U.A. 1994. 1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mcalpain in renal cell carcinoma. Endocrinology, 135(6): 2822-2825. doi:10.1210/en.135.6.2822. PMID:7988478.
20. Rüdiger, H.A., Graf, R., and Clavien, P.A. 2003. Liver ischemia: apoptosis as a central mechanism of injury. J. Invest. Surg. 16(3): 149-159. PMID:12775431.
21. Ruschitzka, F.T., Wenger, R.H., Stallmach, T., Quaschning, T., de Wit, C., Wagner, K., et al. 2000. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc. Natl. Acad. Sci. U.S.A. 97(21): 11609-11613. doi:10.1073/pnas.97.21.11609. PMID: 11027359.
22. Selzner, N., Selzner, M., Jochum, W., and Clavien, P.A. 2003. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J. Hepatol. 39(1): 55-61. doi:10.1016/S0168-8278(03)00147-8. PMID: 12821044.
23. Sepodes, B., Maio, R., Pinto, R., Sharples, E., Oliveira, P., McDonald, M., et al. 2006. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl. Int. 19(11): 919-926. doi:10.1111/j.1432-2277. 2006.00366.x. PMID:17018128.
24. Spandou, E., Tsouchnikas, I., Karkavelas, G., Dounousi, E., Simeonidou, C., Guiba-Tziampiri, O., and Tsakiris, D. 2006. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol. Dial. Transplant. 21(2): 330-336. doi:10.1093/ndt/gfi177. PMID:16221709.
25. Uehara, T., Bennett, B., Sakata, S.T., Satoh, Y., Bilter, G.K., Westwick, J.K., and Brenner, D.A. 2005. JNK mediates hepatic ischemia-reperfusion injury. J. Hepatol. 42(6): 850-859. doi:10. 1016/j.jhep.2005.01.030. PMID:15885356.
26. Vogel, J., Kiessling, I., Heinicke, K., Stallmach, T., Ossent, P., Vogel, O., et al. 2003. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood, 102(6): 2278-2284. doi:10.1182/blood-2003-01-0283.
27. Wiessner, C., Allegrini, P.R., Ekatodramis, D., Jewell, U.R., Stallmach, T., and Gassmann, M. 2001. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21(7): 857-864. doi:10.1097/00004647-200107000-00011. PMID:11435798.
28. Yang, C.W., Li, C., Jung, J.Y., Shin, S.J., Choi, B.S., Lim, S.W., et al. 2003. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 17(12):. PMID:12958199.